Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study - Concepedia

Concepedia

Publication | Open Access

Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study

DOI Full Paper Access

11

Citations

22

References

2022

Year

Fanghui Zhao, Archana Jastorff, Ying Hong, Shangying Hu, Wen Chen, Xiaoqian Xu, Yejiang Zhu, Jiahong Zhu, Xun Zhang, Wen‐Hua Zhang,

Asia-Pacific Journal of Clinical Oncology

Abstract

AS04-HPV-16/18 vaccine showed an acceptable safety profile in Chinese women vaccinated at age 26 years or above, and a long-term protection similar to other efficacy trials worldwide.

References

	Year	Citations

Page 1